ArticleFrontiers in neurology
Associations of non-motor symptoms with perceptual speech impairments in Parkinson's disease.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Communication impairments are common, multifaceted, and progressive symptoms of Parkinson's disease (PD), and have deleterious impacts on individual wellbeing. Self-awareness of communication impairments and the rate and extent of decline in speech skills vary substantially across individuals and are challenging to predict. To address these, we aimed to (1) evaluate associations between non-motor symptoms (NMS) and speech impairment at year seven and (2) compare the progression of self-perceived and examiner-rated speech impairment ratings scores across a seven-year follow-up period. Method: The study included 417 PD participants from the Parkinson's Progression Marker Initiative. NMS were assessed using validated instruments covering sleep, olfaction, neurobehavioral, autonomic, and neuropsychological domains. Speech severity was measured using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Multivariate ordinal logistic regression examined associations between baseline NMS and speech severity at year seven. Changes in speech severity scores over seven years were analyzed using Friedman's test. Results: Several NMS were associated with self-perceived and examiner-rated speech severity at year seven. Baseline REM sleep behavior disorder and autonomic dysfunction were associated with significantly higher odds of speech impairment at year seven. For self-perceived speech, odds ratios (OR) and 95% confidence interval (CI) were 1.58 (1.18-2.12) for REM sleep behavior disorder and 1.71 (1.24-2.36) for autonomic dysfunction. For examiner-rated speech, ORs were 1.45 (1.06-1.98) and 1.71 (1.21-2.42), respectively. Daytime sleepiness was associated with worse examiner-rated speech scores at year seven (OR = 1.51, 95% CI 1.10-2.09). Both self-perceived and examiner-rated speech impairments worsened over seven years ( Conclusion: Several NMS were associated with worse speech ratings at year seven. These simple and readily accessible instruments may help identify individuals at greater risk of worsening speech skills, with the goal of enabling timely and targeted speech and language therapy. The consistency between self-perceived and examiner-rated speech scores suggests individuals with PD maintain good insight into their speech impairments, despite a decline in communication abilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.